CrushSCI.com
Journal Selection & Manuscript Polishing Services
EJNMMI Research journal cover Medicine
Back to journal directory

Review Cycle Records

EJNMMI Research

Springer SCIE OA
2026 Emerging Zone 32025 CAS Zone 32025 JCR Q2
126.5Average days
122Median days
41Fastest days
190Longest days
1652025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

176 days

Correlation of [ 18 F]SiTATE-PET-tracer with somatostatin receptor expression in meningiomas: an exploratory ex vivo histological pilot study

AuthorsRieke Gerdes; Jens Schittenhelm; Stephan Singer; Gerald Reischl; Hannes Becker; Marcos Tatagiba; Salvador G. Castaneda-Vega; Christian la Fougère; Benjamin Bender; Nils F. Trautwein

Affiliations1. Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tuebingen, Tuebingen, Germany; 2. Institute of Neuropathology, Department of Pathology and Neuropathology, University Hospital Tuebingen, Tuebingen, Germany; 3. Department of General and Molecular Pathology and Pathological Anatomy, University Hospital Tuebingen, Tuebingen, Germany; 4. Department of Preclinical Imaging and Radiopharmacy, University Hospital Tuebingen, Tuebingen, Germany; 5. Department of Neurosurgery, University Hospital Tuebingen, Tuebingen, Germany; 6. Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tuebingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tuebingen, Tuebingen, Baden-Wuerttemberg, Germany; 7. DFG Cluster of Excellence 2180 ‘Image-Guided and Functional Instructed Tumor Therapy’ (iFIT), University of Tuebingen, Tuebingen, Germany; 8. German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) Partner Site Tuebingen, Tuebingen, Germany; 9. Department of Neuroradiology, University Hospital Tuebingen, Tuebingen, Germany

Source PDF DOI Publisher page
115 days

[ 18 F]FDG PET/CT as an endpoint marker in drug interventional studies in atherosclerosis - a structured review

AuthorsCasper E. W. Gijsen; Felix M. Mottaghy; Ahmed Tawakol; Joachim E. Wildberger; Jan Bucerius

Affiliations1. Department of Radiology and Nuclear Medicine, Maastricht University Medical Center (MUMC⁺), Maastricht, the Netherlands; 2. Department of Nuclear Medicine, University Hospital RWTH Aachen, Aachen, Germany; 3. Cardiovascular Imaging Research Center, Massachusetts General Hospital, Boston, USA; 4. Department of Medicine, Division of Cardiology, Massachusetts General Hospital, Boston, USA; 5. Cardiovascular Research Institute (CARIM), Maastricht University Medical Center (MUMC⁺), Maastricht, the Netherlands; 6. Division of Nuclear Medicine, Department of Radiology, Medical University of Graz, Graz, Austria

Source PDF DOI Publisher page
41 days

Biodistribution and dosimetry of the carbon-11 labelled PARP1-selective PET radiopharmaceutical [ 11 C]AZ14193391

AuthorsAnders Törnblom; Cecilia He; Martin Bolin; Antonios Tzortzakakis; Josefin Fernebro; Chunde Li; Susanne Fridsten; Renske Altena; Rimma Axelsson; Jonathan Siikanen; Cecilia Hindorf

Affiliations1. Department of Nuclear Medicine and Medical Physics Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden; 2. Division of Molecular Medicine and Surgery (MMK), Karolinska Institutet, Stockholm, Sweden; 3. Division of Radiology Department for Clinical Science Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden; 4. Centre for Psychiatry Research Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services Region, Stockholm, Sweden; 5. Department of Nuclear Medicine and Medical Physics Theranostics Trial Center, Karolinska University Hospital, Stockholm, Sweden; 6. Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; 7. Section of Gynecological Oncology, Karolinska University Hospital, Stockholm, Sweden; 8. Department of Oncology, Södersjukhuset, Stockholm, Sweden; 9. Department of Clinical Science and Education, Karolinska Institutet Södersjukhuset, Stockholm, Sweden

Source PDF DOI Publisher page
132 days

Evaluation of the biodistribution of [ 99m Tc]Tc-PSMA-GCK01 SPECT/CT in a prospective, intraindividual comparison with [ 68 Ga]PSMA-11 PET/CT for phenotyping in mCRPC prior to PSMA-targeted radioligand therapy

AuthorsEmil Novruzov; Eduards Mamlins; Joseph Kabunda; Jens Cardinale; Milani Qebetu; Clemens Kratochwil; Anna Feisthauer; Stefan Martlbauer; Chimbabantu Alexis Kaoma; Sandile Sibiya; Tertia de Bruin; Sipho Mdanda; Mbongeni Shungube; Cindy Davis; Liani Smith; Yonwaba Mzizi; Kgomotso Mokoala; Honest Ndlovu; Keamogetswe Ramonaheng; Frederik L. Giesel; Mike M Sathekge

Affiliations1. Department of Nuclear Medicine, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany; 2. Centre for Integrated Oncology (CIO) Duesseldorf, CIO Aachen-Bonn-Cologne-Duesseldorf, Duesseldorf, Germany; 3. Department of Nuclear Medicine, University of Pretoria and Steve Biko Academic Hospital, Pretoria, South Africa; 4. Nuclear Medicine Research Infrastructure (NuMeRI), Pretoria, South Africa; 5. Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany

Source PDF DOI Publisher page
98 days

[ 161 Tb]Tb-DOTATATE as a potential treatment option for neuroblastoma

AuthorsSaloni Chopra; Tianqi Xu; Hanna Berglund; Amanda Gustafsson; Marika Nestor

Affiliations1. Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden

Source PDF DOI Publisher page
117 days

Early detection and localization of recurrent prostate cancer using \(^{18}\) F-DCFPyL PET/CT in patients with low and ultra-low PSA levels

AuthorsIda Sonni; Alexandra Gulpe; Nicholas G. Nickols; Derace Schaffer; Louis Montagut; Gholam R. Berenji; Matthew B. Rettig

Affiliations1. Department of Radiological Sciences, University of California, Los Angeles, USA; 2. Department of Nuclear Medicine, VA Greater Los Angeles Healthcare System, Los Angeles, USA; 3. EXINI Diagnostics AB, Lund, Sweden; 4. Department of Radiation Oncology, University of California, Los Angeles, USA; 5. Department of Radiation Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, USA; 6. Department of Urology, University of California, Los Angeles, USA; 7. Concord Academy, Concord, USA; 8. Department of Medicine, University of California, Los Angeles, USA; 9. Department of Medicine, Division of Hematology-Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, USA

Source PDF DOI Publisher page
162 days

Head-to-head comparison of 99m Tc-MIP-1404 CZT SPECT/CT and 68 Ga/PSMA-11 PET/CT for primary staging of high-risk prostate cancer: a phase II study

AuthorsAws Saudi; Malin Ståhlgren; Prab Takhar; Pernilla Norberg; Martin Holmbom; Julia Dahl; Mostafa Afshar; Isidro Albert-García; Jon Forsberg; Marcus Ressner; Mathias Elgland; Veronica Sanchez-Rodriguez; Firas Aljabery; Miguel Ochoa-Figueroa

Affiliations1. Department of Clinical and Experimental Medicine, Division of Urology, Linköping University, Linköping, Sweden; 2. Department of Radiology in Linköping, Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden; 3. Curium Pharma (Nordics), Curium Pharma Finland OY, Helsinki, Finland; 4. Clinical Department of Medical Radiation Physics, Region Östergötland, Linköping, Sweden; 5. Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden; 6. Department of Clinical Physiology in Linköping, Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden; 7. Department of Nuclear Medicine and Medical Radiation Physics, Karolinska University Hospital, Stockholm, Sweden; 8. Department of Radiology, Section for Molecular Imaging, Institution for Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden; 9. Center for Medical Image Science and Visualization (CMIV), Linköping University, Linköping, Sweden

Source PDF DOI Publisher page
190 days

Preclinical evaluation of [ 18 F]fluoroethylresorufin as PET tracer for cerebral amyloid angiopathy

AuthorsDaniel Bleher; Marilena Poxleitner; Ann-Kathrin Grotegerd; Oliver Hihn; Laura Kuebler; Gregory Bowden; Martin Schaller; Florian C. Maier; Bettina Weigelin; Bernd J. Pichler; Andreas Maurer; Kristina Herfert

Affiliations1. Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, University of Tübingen, Tübingen, Germany; 2. Cluster of Excellence iFIT (EXC 2180) Image Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany; 3. Department of Dermatology, University of Tübingen, Tübingen, Germany

Source PDF DOI Publisher page
107 days

Sarcopenia does not affect total liver function measured using technetium-99m mebrofenin hepatobiliary scintigraphy

AuthorsPieter Arntz; Pim Olthof; Fadi Rassam; Roelof Bennink; Robert-Jan Coelen; Thomas van Gulik; Jan Heil; Geert Kazemier; Bart Takkenberg; Joris Erdmann

Affiliations1. Cancer Center Amsterdam, Amsterdam UMC, Department of Surgery, University of Amsterdam, VUMC, Amsterdam, The Netherlands; 2. Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; 3. Cancer Center Amsterdam, Amsterdam UMC, Department of Radiology and Nuclear Medicine, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; 4. Department of General, Visceral and Transplant Surgery, University Hospital Frankfurt, Goethe-University Frankfurt, Frankfurt am Main, Germany; 5. Cancer Center Amsterdam, Amsterdam UMC, Department of Surgery, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; 6. Location Academic Medical Center, Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands

Source PDF DOI Publisher page
127 days

Radioluminescence microscopy of tumor organoids enabled by a reconfigurable high-resolution imaging setup

AuthorsSofia Demianova; Martin Dierolf; Maximilian Reichert; Laura Schmidleitner; Franz Pfeiffer; Wolfgang A. Weber

Affiliations1. Chair of Biomedical Physics, Department of Physics, TUM School of Natural Sciences, Technical University of Munich, Garching, Germany; 2. Munich Institute of Biomedical Engineering (MIBE), Technical University of Munich, Garching, Germany; 3. Center for Translational Pancreatic Cancer Research, TUM School of Medicine and Health, Clinical Department for Internal Medicine II, TUM University Hospital, Munich, Germany; 4. Center for Organoid Systems (COS), Technical University of Munich, Garching, Germany; 5. TUM Institute for Advanced Study, Technical University of Munich, Garching, Germany; 6. Department of Nuclear Medicine, TUM University Hospital, Klinikum rechts der Isar, Munich, Germany; 7. Bavarian Cancer Research Center (BZKF), Munich, Germany

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.